Coherus Biosciences | CHRS - Revenu Net

Prix De L'Action
1.52
Variation Quotidienne
-0.09 -5.59%
Mensuellement
-6.17%
Annuel
47.57%
Q1 Prévisions
1.47




Revenu Net Changement Date
AbbVie USD 1.82B 1.63B 2025-12
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
Akebia Therapeutics USD -12.24M 12.78M 2025-12
ALKERMES USD 49.34M 33.42M 2025-12
Alnylam Pharmaceuticals USD 186.42M 64.66M 2025-12
Amarin USD -1.22M 6.51M 2025-12
Amgen USD 1.33B 1.88B 2025-12
Baxter International USD -1.13B 1.08B 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Coherus Biosciences USD -37.64M 2.11M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Fujifilm JPY 72.66B 6.27B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Merck USD 2.96B 2.82B 2025-12
Myriad Genetics USD -7.9M 19.5M 2025-12
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD -134.96M 150.86M 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Sarepta Therapeutics USD -412.23M 232.28M 2025-12
Teva Pharmaceutical Industries USD 480M 47M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Xencor USD -6.65M 626K 2025-12
Zoetis USD 603M 118M 2025-12